|
Merck & Co., Inc. announced a voluntary withdrawal of Vioxx (rofecoxib)
from the U.S. and worldwide market due to safety concerns of an
increased risk of cardiovascular events (including heart attack and
stroke) in patients on Vioxx. Vioxx is a prescription COX-2
selective, non-steroidal anti-inflammatory drug (NSAID) that was
approved by FDA in May 1999 for the relief of the signs and symptoms
of osteoarthritis, for the management of acute pain in adults, and for
the treatment of menstrual symptoms. Vioxx was later approved for the
relief of the signs and symptoms of rheumatoid arthritis in adults and
children.
If you would like more information on pursuing a claim for
damages due to Vioxx use please contact a lawyer / attorney to discuss your options
regarding filing a possible lawsuit.
Home >
Vioxx Lawsuit |